Tolperisone clinical trials
How each study uses Tolperisone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2019 | 2 |
| 2020 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Neurana Pharmaceuticals, Inc. (4) · Avigen (2) · Semmelweis University (1)
Studies
Open first, then newest update. How each study uses Tolperisone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"Active, not recruitingPhase 3Semmelweis UniversityNCT05544656Written as Tolperisone Hydrochloride
- Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle SpasmCompletedPhase 3Neurana Pharmaceuticals, Inc.NCT04671082Written as Tolperisone Hydrochloride
- Tolperisone in Acute Muscle Spasm of the BackCompletedPhase 2Neurana Pharmaceuticals, Inc.NCT03802565Written as Tolperisone
- A Phase 1 PK Study of Tolperisone in Healthy SubjectsCompletedPhase 1Neurana Pharmaceuticals, Inc.NCT04465266Written as Tolperisone
- Effects of Tolperisone on Measures of Drowsiness and Cognitive FunctionCompletedPhase 1Neurana Pharmaceuticals, Inc.NCT04407377Written as Tolperisone Hydrochloride
- Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord InjuryTerminatedPhase 2AvigenNCT00531466Written as tolperisone HCl (AV650)
- Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple SclerosisTerminatedPhase 2AvigenNCT00532532Written as tolperisone HCl
Codes
What other systems call Tolperisone · ClinicalTrials.gg INT008335
- MeSH (NLM) D014049TolperisoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F5EOM0LD8ETOLPERISONEConfirmed FDA, NLM, Wikidata
- RxNorm 10639Confirmed FDA, Wikidata
- Wikidata Q369648tolperisoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C84219TolperisoneOne source FDA
- DrugBank DB06264One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014049 | Tolperisone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F5EOM0LD8E | TOLPERISONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10639 | — | Confirmed FDA, Wikidata |
| Wikidata | Q369648 | tolperisone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C84219 | Tolperisone | One source FDA |
| DrugBank | DB06264 | — | One source Wikidata |
Also registered as tolperisone hydrochloride (UNII 8Z075K2TIG).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.